Global Blood Therapeutics announces changes to board of directors
Global Blood Therapeutics announced the appointment of Mike Bonney, partner at Third Rock Ventures, and Glenn Pierce, M.D., Ph.D., formerly CMO at Biogen, to its Board of Directors. The company also announced that Kevin Starr, partner at Third Rock Ventures, will retire from the Board. February 08, 2016